Tempest TherapeuticsTPST
13F holders, Q2 2025 (June 30)1holders −21
1new positions
8sold out
$6.80avg. 13F price*
At the end of Q2 2025, 1 institutions reported holding Tempest Therapeutics Inc. (TPST) in their 13F filings, down 21 from Q1 2025. 1 opened new positions and 8 sold out. The largest holder was Versant Venture Management, LLC ($1.8M).
- Company
- Tempest Therapeutics Inc.
- CUSIP
- 87978U108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1.8M |
| Exits | 8 | $164K |
All 13F filers, Q1 2025 → Q2 2025: 269,772 shares bought and 222,183 shares sold, net +47,589 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Versant Venture Management, LLC | 2.23% | New | 269,772 | $1.8M |
"% of holder's portfolio" is TPST's weight in each manager's 13F, not the share of Tempest Therapeutics Inc. the manager owns.